Reuters logo
BRIEF-Acura Pharmaceuticals Inc says FDA has provided company with advice on development of its product candidate LTX-04
December 14, 2016 / 10:27 PM / 9 months ago

BRIEF-Acura Pharmaceuticals Inc says FDA has provided company with advice on development of its product candidate LTX-04

Dec 14 (Reuters) - Acura Pharmaceuticals Inc :

* Acura Pharmaceuticals says FDA confirmed company’s stated direction to reformulate ltx-04 to provide greater levels of drug in blood stream

* Acura Pharmaceuticals - in study ap-ltx-400, ltx-04 tablets delivered about 50% of maximum drug concentration in blood stream

* Acura Pharmaceuticals Inc says U.S. FDA has provided company with advice on continued development of its product candidate ltx-04

* Says FDA’s advice also identified longer term studies necessary for submitting a new drug application for ltx-04 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below